Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Three trials simultaneously...

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Oct 10, 2022 9:38pm

186 Views

Post# 35016353

RE:RE:RE:RE:Three trials simultaneously...

Still at it Infinity? Still having problems understadning that different stages require different type of investors?

Money with connections is what's important from now on. Too hard for you to understand?

And an hostile takeover = no maximization of the potential.

Funny that you're ready to settle for peanuts instead of true value, when you own shares in a technology that destroys solid tumors, not just shrink them like competition.

And you whine on TLT management???

Get lost!

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China